Multiple Sclerosis and Neuroimmunology

The Queen’s Neuroscience Institute offers care for patients with multiple sclerosis (MS) and other inflammatory disorders affecting the central nervous system. Our Center provides focused care dedicated to the comprehensive diagnosis and treatment of neuroinflammatory disorders. We treat patients of all ages, ranging from pediatrics to elderly patients, including specialized considerations for women of childbearing age. We work closely with the National Multiple Sclerosis Society to provide patients support and guidance, both locally and nationally. We serve as educational guidance for patients and family members as well as other healthcare providers.

What is Multiple Sclerosis

Multiple Sclerosis is a disease of the central nervous system mediated by impairments in immune function. MS causes destruction of myelin, the insulation surrounding the nerve fibers in the brain and spinal cord. This leads to slowing of signal transmission through the central nervous system and causes a variety of symptoms including weakness, numbness, bladder/bowel symptoms, imbalance, fatigue, heat sensitivity, mood disturbance, and cognitive slowing. There is no one test to determine MS. The diagnosis of MS is based on clinical symptoms, MRI results, and sometimes electrophysiologic and cerebrospinal fluid analyses.